Contribute Try STAT+ Today

Pharma

Taking stock of the drug industry, from the lab to the medicine chest. For a weekly update, sign up for our free Pharmalot newsletter. And subscribe to STAT+ for exclusive coverage and analysis of the pharma industry — from drug pipelines to boardroom shakeups.

FDA stop sign

Pharmalot By Ed Silverman

FDA to importer: keep your active pharma ingredients away from weed killer and antifreeze

Syntec Pharma also had personal food items in a refrigerator used to store active ingredients and chemicals.

Cash back

Pharmalot By Ed Silverman

‘Deeply disappointed’: FTC pulls pay-to-delay case after losing authority to force drug makers to relinquish profits

Porous Silica Nanoparticles

Biotech By Elizabeth Cooney

How nanotechnology helps mRNA Covid-19 vaccines work

Virus Outbreak Kids Heart Inflammation

Health By Lauran Neergaard — Associated Press

Pfizer to seek FDA authorization for third, booster dose of its Covid-19 vaccine

20th century cash

Pharmalot By Ed Silverman

FDA threatens to fine another drug maker for failing to report clinical trial results

All Coverage

Alexion Pharmaceuticals Inc

Pharmalot By Ed Silverman

Canadian agency loses a battle in effort to force a drug maker to lower ‘excessive’ pricing

Pharmalot By Ed Silverman

Pharmalittle: FDA aims to fully approve Pfizer Covid-19 vaccine by Labor Day; SoftBank grabs $5 billion stake in Roche

advertisement

Pharmalot By Ed Silverman

Pharmalittle: Sanofi to pay $3.2 billion to buy Translate Bio; COVAX struggles with Covid-19 vaccine distribution

Pharmalot By Ed Silverman

Pharmalittle: Pfizer and Moderna raise Covid-19 vaccine prices for Europe; FDA to speed full approval of Pfizer shot

Pharmalot Coming/Going STILL

Pharmalot By Ed Silverman

Up and down the ladder: The latest comings and goings

Pharmalot By Damian Garde

Pharmalittle: Remdesivir props up Gilead’s declining fortunes; U.K. fines drug maker for price hikes

Pharmalot By Ed Silverman

Pharmalittle: Emergent to resume Covid-19 vaccine production; FDA OKs first interchangeable biosimilar insulin

insulin biosimilar

Pharmalot By Ed Silverman

FDA approves the first interchangeable biosimilar insulin. Will it really lower the cost?

pill shopping cart

Pharmalot By Ed Silverman

Lawmakers ask Defense Department about using a controversial maneuver to lower drug prices

Pharmalot By Ed Silverman

Pharmalittle: Biogen yanks Alzheimer’s paper from JAMA over edits; Pfizer sees $33.5 billion in Covid-19 vax sales

Mice, the problem with

Pharmalot By Ed Silverman

Animal rights activists get new ammunition in their battle over a controversial rodent test

Pharmalot By Ed Silverman

Pharmalittle: Pharma lobbies Congress on global tax proposal; the FDA doc at center of Aduhelm controversy

Painkillers

Pharmalot By Ed Silverman

Purdue says most creditors voted in favor of contentious bankruptcy plan

pharmaceutical plant closure

The Pharmalot View By Ed Silverman

Biden wants to bolster the pharma supply chain. A major generic plant closing may make that harder

Pharmalot By Ed Silverman

Pharmalittle: A race to develop Covid-19 pills is underway; Russian trolls target Pfizer vaccine

Pharmalot Coming/Going STILL

Pharmalot By Ed Silverman

Up and down the ladder: The latest comings and goings

Pharmalot By Elizabeth Cooney

Pharmalittle: Biogen’s ‘symptom quiz’ for Aduhelm draws fire; most U.S. clinical trials flunk transparency rules

magnifying glass w/ reports

Pharmalot By Ed Silverman

Most clinical trials failed to meet U.S. transparency requirements for recently approved drugs

Pharmalot By Ed Silverman

Pharmalittle: Biogen defends its controversial Alzheimer’s drug; critics pan Pfizer plan for Covid-19 shot production in Africa

Pfizer Albert Bourla

Pharmalot By Ed Silverman

Pfizer looks to widen access to Covid-19 vaccine in Africa, but advocates say it doesn’t go far enough

Johnson & Johnson sign

Pharmalot By Ed Silverman

States reach $26 billion deal with three wholesalers and J&J to end opioid lawsuits

Pharmalot By Ed Silverman

Pharmalittle: Pfizer cuts deal for Covid-19 shot to be partially made in South Africa; wholesalers to pay $1.1b to NY to settle opioid suit

Paper cup pills nonadherent noncompliant

Pharmalot By Ed Silverman

FDA plans to study whether pharma reps at conference exhibit booths are telling the truth

OPIOID photo ILLUSTRATION

Pharmalot By Ed Silverman

Three pharma wholesalers reach a $1.1 billion deal with New York over the opioid crisis